News & Events

Sentry Stands with Ryan White Clinics as Study Highlights Importance of Funding and 340B Program in Managing HIV/AIDS Epidemic

The following article highlighting the RWC-340B Reduction in Resources White Paper was posted on the PR Newswire website on October 26, 2020.  Sentry Data Systems,

27 Oct 2020

Cancer Care and the 340B Program: “People in underserved communities don’t want to be test subjects”

The following article highlighting the Association for Value-Based Cancer Care 2020 Summit was posted on the AVBCC website on October 20, 2020
On October 8, 2020,

21 Oct 2020

RWC-340B and 340B Grantee Plaintiffs File Lawsuit Against HHS/HRSA to Protect 340B Contract Pharmacy Program from Manufacturer Attacks

On October 9, 2020, RWC-340B and two of its member 340B grantee clinics, Cempa Community Cares and Matthew 25 AIDS Services, Inc., filed a lawsuit

12 Oct 2020

Discriminatory Reimbursement Practices by PBMs Represent a Threat to Public Health: A Perspective from Community Health

The following editorial from Shannon Stephenson, CEO of Cempa Community Care, President of RWC-340B was posted in Drug Channels on October 9, 2020
Manufacturers and covered

9 Oct 2020

Op Ed: “Keep up the progress against HIV and AIDS”

The following editorial from Mike Lee, COO of Evergreen Health, Secretary of RWC-340B was posted in the New York Daily News on September 16, 2020

16 Sep 2020

Congressional Letters to Secretary Azar to Object to Manufacturer Actions

Thanks to efforts by RWC-340B members and other covered entity advocates, 243 members of the House of Representatives (174 Democrat and 69 Republican members) signed

15 Sep 2020

RWC-340B Submits Letter to HHS Regarding Drug Manufacturers Actions That Undermine the 340B Program & Letter to HRSA Regarding 340B Telehealth Policies

Today, RWC-340B submitted to a letter to Secretary of the U.S. Department of Health and Human Services (HHS) Alex Azar requesting that HHS initiate enforcement

11 Sep 2020

Eli Lilly Announces New Limited Distribution Plan

In a notice sent to covered entities and other 340B program participants, Eli Lilly and Co. (Lilly) announced that, effective September 1, 2020, it is

1 Sep 2020

Recap of Second 340B ESP™ Basic User Training Webinar

On August 26, Second Sight Solutions, the owner of the 340B ESP™ platform, hosted the second in a series of webinars on 340B ESP™.  The

28 Aug 2020

RWC-340B Press Statement on Recent Actions Taken by Drug Manufacturers

Here is a press statement from RWC-340B president Shannon Stephenson regarding the recent actions taken by drug manufacturers Lilly, Novartis, Merck, Sanofi, and Astra Zeneca. 

27 Aug 2020